The company will establish a new 700,000-square-foot, high-volume fill-finish operation in Wake County to support its existing product portfolio as well as its future pipeline, allowing Genentech ...

Genentech has secured a second marketed stroke therapy after the US Food and Drug Administration (FDA) approved a label expansion for clot-dissolving agent TNKase (tenecteplase) – the first ...

Instil Bio, Inc. ("Instil") (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announced ...

The crypto bull run, which began in early 2024, has the potential to continue until 2026, according to historical patterns and insights from a chart dating back to 1875. This chart, which predicts ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine program. Back in 2020, the Roche subsidiary inked a worldwide licensing ...

You can reach Jonathan on Signal at jwosen.27. For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have ...

Also, the chart below shows the recent historical and expected future growth path of the epilepsy diagnosis and treatment market through 2032: ...

Genentech, a leading biotechnology company, recently announced the permanent closing of their Cancer Immunology Department. This announcement comes as a major surprise in the scientific community.

Hornby, who has been with the firm since May 2019 and was previously COO of Ignyta, a precision oncology company acquired by Roche/Genentech ... the chart below shows the historical and projected ...

Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics. On Nov. 21, 2023, Genentech, ...